ClinicalTrials.Veeva

Menu

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Sonova logo

Sonova

Status

Completed

Conditions

Tinnitus
Hearing Loss, Sensorineural

Treatments

Device: hearing aid amplification
Device: hearing aid amplification with an added sound

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT05292534
SRF-481

Details and patient eligibility

About

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

Full description

2 groups of adults with hearing loss and chronic bothersome tinnitus and no experience with amplification will participate in a cross over intervention study with 2 conditions of 4 weeks each: 1. fit with hearing aid (HA) amplification-only, and 2. fit with HA amplification with an added sound, returning to their original unaided condition after undergoing the intervention phase.

Enrollment

38 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hearing loss
  • candidate for hearing aid amplification
  • Bothersome chronic tinnitus (3 months+)

Exclusion criteria

  • age less than 18 years
  • normal hearing
  • tinnitus presence for less than 3 months
  • tinnitus not bothersome enough to warrant intervention
  • non hearing aid candidates

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

38 participants in 3 patient groups

Amplification-only
Active Comparator group
Description:
Hearing aid will be fit to prescribed participant hearing loss.
Treatment:
Device: hearing aid amplification
Amplification with added sound
Active Comparator group
Description:
Hearing aid will be fit to prescribed participant hearing loss and an added sound will be activated on the hearing aid.
Treatment:
Device: hearing aid amplification with an added sound
No intervention
No Intervention group
Description:
Participants will return to their original unaided state.

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Ieda Ishida, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems